ƒz[ƒ€ > ­ô‚ɂ‚¢‚Ä > •ª–ì•Ê‚Ì­ôˆê—— > ‘¼•ª–ì‚ÌŽæ‚è‘g‚Ý > Œ¤‹†Ž–‹Æ > ˆÈ‘Oi•½¬9`22”N“xjŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à‚ÌŠT—v > •½¬22”N“xŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à‚ÌŠT—v > ’†ŠÔEŽ–Œã•]‰¿ˆÏˆõ‰ï–¼•ë > zŠÂŠíŽ¾Š³E“œ”A•a“™¶ŠˆKŠµ•a‘Îô‘‡Œ¤‹†Ž–‹Æ@’†ŠÔEŽ–Œã•]‰¿ˆÏˆõ–¼•ë

zŠÂŠíŽ¾Š³E“œ”A•a“™¶ŠˆKŠµ•a‘Îô‘‡Œ¤‹†Ž–‹Æ@’†ŠÔEŽ–Œã•]‰¿ˆÏˆõ–¼•ë

i›FˆÏˆõ’·j

 
‘Šì@’¼Ž÷ Œcœä‹`m‘åŠw–¼—_‹³Žö
iàj‘ÛˆãŠwî•ñƒZƒ“ƒ^[—Ž–’·
‹~‹}ˆãŠw
Application of the recent American practice resources for risk stratification system for patients presenting to a Japanese emergency department because of syncope. Suzuki M, Hori S, Aikawa N: Internationla Heart Journal 2007; 48: 513-522.
Aikawa N, Shimazaki S, Yamamoto Y, Saito H, Maruyama Y, Ohno R, Hirayama A, Aoki Y, Aoki N: Thrombomodulin alfa in the treatment of inferctious patients complicated by intravascular coagulation: subanalysis from a phase III trial. Shock 2010F(DOI:10.1097/SHK.Ob013e3318204c019)
u‹~‹}ƒŒƒWƒfƒ“ƒgƒ}ƒjƒ…ƒAƒ‹@‘æ4”ÅEv‘Šì’¼Ž÷E–x@iŒå@•Ò’˜CˆãŠw‘‰@Ai2010j
 
”‘q@Od ˆïéƒLƒŠƒXƒg‹³‘åŠw@–¼—_‹³Žö
—Õ°‰h—{ŠwAŽ‰Ž¿‘ãŽÓŠwA“®–¬d‰»Šw
Reletionship Between Coronary Events and Serum Cholesterol During 10 Years of Low-Dose Simvastatin Therapy --- Long-Term Efficacy and Safety in Japanese Patients With Hypercholesterolemia in the Japan Lipid Intervention Trial (J-LIT) Extension 10 Study, a Prospective Large-Scale Observational Cohort Study ---
Hiroshige Itakura, Toru Kita, Hiroshi Mabuchi, Masunori Matsuzaki, Yuji Matsuzawa, Noriaki Nakaya, Shinichi Oikawa, Jun Sasaki, Kazuaki Shimamoto.
Circulation Journal, 72: 1218-1224, 2008
Obesity as a Risk Factor for Coronary Events in Japanese Patients with Hypercholesterolemia on Low-Dose Simvastatin Therapy.
Yasushi Saito, Toru Kita, Hiroshi Mabuchi, Masunori Matsuzaki, Yuji Matsuzawa, Noriaki Nakaya, Shinichi Oikawa, Jun Sasaki, Kazuaki Shimamoto, and Hiroshige Itakura.
J Atheroscler Thromb, 17: 270-277,2010
Long-term event monitoring study of fluvastatin in Japanese patients with hypercholesterolemia : Efficacy and incidence of cardiac and other events in elderly patients(†years old).
Hiroshige Itakura, Noriaki Nakaya, Tadashi Kusunoki, Naokata Shimizu, Shunsaku Hirai, Seibu Mochizuki, Toshitsugu Ishikawa.
Journal of Cardiology 57; 77-88, 2011
 
¬—Ñ@š ’j ’é‹ž•½¬‘åŠwŒ’NƒƒfƒBƒJƒ‹Šw•”‹³Žö
‹~‹}ˆãŠwAŠOŠO‰ÈŠw
K. Kobayashi, H. Ikeda, R. Higuchi, M. Nozaki, Y. Yamamoto, M. Urabe, S. Shimazaki, A. Sugamata, N. Aikawa, N. Ninomiya, H. Sakurai, Y. Hamabe, N. Yahagi, H. Nakazawa : Epidemiological and outcome characteristics of major burns in Tokyo. Burns 31S(2005) : S3 - S11.
K. Kobayashi : Challenges for improving trauma care in Japan.@@@ J Trauma 2005; 58:1134 -1139.
¬—Ñ‘’jFD‚«‚É‚È‚é‹~‹}ˆãŠw. u’kŽÐƒTƒCƒGƒ“ƒeƒBƒtƒBƒbƒNA“Œ‹žA2006.
 
™è@“OŽO º˜a‘åŠw –¼—_‹³Žö
t‘Ÿ•aAƒŠƒ…ƒEƒ}ƒ`äPŒ´•a
Elevated urinary plasmin activity resistant to alpha2-antiplasmin in acute poststreptococcal glomerulonephritis.
Oda T, Tamura K, Yoshizawa N, Sugisaki T, Matsumoto K, Hattori M, Sawai T, Namikoshi T, Yamada M, Kikuchi Y, Suzuki S, Miura S.
Nephrol Dial Transplant. 2008 Jul;23(7):2254-9.
Diagnosing Alport syndrome using electron microscopy of the skin.
Kuroki A, Ito J, Yokochi A, Kato N, Sugisaki T, Sueki H, Akizawa T.
Kidney Int. 2008 Feb;73(3):364-5.
Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy.
Kuroki A, Iyoda M, Shibata T, Sugisaki T.
Kidney Int. 2005 Jul;68(1):302-10.
 
´–ì@—T ŠÖ¼“d—Í•a‰@@‰@’·
“œ”A•aŠw
Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice
Maida A, Hansotia T, Longuet C, Seino Y, Drucker DJ.
Gastroenterology. 2009 Dec;137(6):2146-57. Epub 2009 Sep 17.
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, Hiai H, Mizunoya W, Fushiki T, Holst JJ, Makino M, Tashita A, Kobara Y, Tsubamoto Y, Jinnouchi T, Jomori T, Seino Y.
Nat Med. 2002 Jul;8(7):738-42. Epub 2002 Jun 17.
Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice
Miyawaki K, Yamada Y, Yano H, Niwa H, Ban N, Ihara Y, Kubota A, Fujimoto S, Kajikawa M, Kuroe A, Tsuda K, Hashimoto H, Yamashita T, Jomori T, Tashiro F, Miyazaki J, Seino Y.@@Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14843-7.
 
“c’†@•½ŽO _“ÞìH‰È‘åŠw‰ž—pƒoƒCƒI‰ÈŠw•”‰h—{¶–½‰ÈŠw‰ÈE‹³Žö
ŒöO‰q¶Šwi‰uŠwjAŒöO‰h—{ŠwA‰h—{EH•i­ôŠw
Gen Kobashi, Heizo Tanaka, et al: FokI variant of vitamin D receptor
gene and factors related to athero-sclerosis associated with ossification of the posterior longitudinal ligament of the spine.
Spine 2008;33(16):E553`E558
Detels R, McEwen J, Beaglehole R,Tanaka H edD: Oxford Textbook of
Public Health, 4th EditionDOxford Uni Press, Oxford New York,2002
“c’†•½ŽOA“¿—¯MŠ°AˆÉ’B‚¿‚®‚³A²X–Ø•q•Ò’˜: ŒöO‰h—{Šw@‰ü’ù‘æ‚R”ÅD@“ì]“°A“Œ‹žA2010
 
•x‰i@—S–¯ ˆ¤’mŒ§‚ª‚ñƒZƒ“ƒ^[–¼—_‘’·
‚ª‚ñ‚̉uŠwE—\–hA¶ŠˆKŠµ•a‚Ì—\–hA‹i‰Œ‘Îô
“ú–{‹Ö‰Œ‰ÈŠw‰ï•ÒiŠÄCF‹g“cCA•ÒWF•x‰i—S–¯A’†Œ´r—²A‚‹´—TŽqj‹Ö‰ŒŽw“±EŽx‰‡ŽÒ‚Ì‚½‚ß‚Ì‹Ö‰Œ‰ÈŠwA1-471•ÅA•ªŒõ“°A2007
•x‰i—S–¯F‚ª‚ñ‚Ì—\–h\Œ’N‚­‚èE¶ŠˆKŠµ•a‚Ì—\–hA43-51•ÅA‘æ33‰ñ“ú–{ƒgƒLƒVƒRƒƒW[Šw‰ïŠwp”N‰ï2006A2007@iu‰‰‹L˜^Wj
•ŒG´AÎì—T“NA‘£{”üŽqA‹v–ìŒOA’ɺˆê‘ãA•x‰i—S–¯FŒãŠú‚—îŽÒ‚ɑ΂·‚錒N“x•]‰¿‚Æ‚µ‚Ä‚ÌŽ©“]ŽÔƒGƒ‹ƒSƒ[ƒ^‚É‚æ‚é‰^“®•‰‰×ŽŽŒ±‚Ì—L—p«A“ú–{Œö‰qŽA52(6):468-476,2005
 
ŒËŽR@–Fº Œcœä‹`m‘åŠwˆãŠw•”®Œ`ŠO‰ÈŠw@‹³Žö
Œcœä‹`m@í”C—Ž–
®Œ`ŠO‰ÈŠw
Osahiko Tsuji, Kyoko Miura, Yohei Okada, Kanehiro Fujiyoshi,
Masahiko Mukaino, Narihito Nagoshi, Kazuya Kitamura, Gentaro Kumagai,
Makoto Nishino, Shuta Tomisato, Hisanobu Higashi,Toshihiro Nagai,
Hiroyuki Katoh, Kazuhisa Kohda, Yumi Matsuzaki, Michisuke Yuzaki,
Eiji Ikeda, Yoshiaki Toyama, Masaya Nakamura, Shinya Yamanaka,
Hideyuki Okano: Therapeutic potential of appropriately evaluated
safe-induced pluripotent stem cells for spinal cord injury.      
 Proceedings of the National Academy of Sciences of the USA
 107(28):12704-12709,2010.
Akihiro Hakozaki, Masaki Yoda, Takahide Tohmonda, Mitsuru Furukawa,
Tomohiro Hikata, Shinichi Uchikawa, Hironari Takaishi, Morio Matsumoto,Kazuhiro Chiba, Keisuke Horiuchi, Yoshiaki Toyama: Receptor activator
of NF-κB(RANK) ligand induces ectodomain shedding of RANK in murine
RAW264.7 macrophages.
 J Immunology    184:2442-2448,2010.
Yoshiteru Miyauchi, Ken Ninomiya, Hiroya Miyamoto, Akemi Sakamoto,
Ryotaro Iwasaki, Hiroko Hoshi, Kana Miyamoto, Wu Hao, Shigeyuki Yoshida,
Hideo Morioka, Kazuhiro Chiba, Shigeaki Kato, Takeshi Tokuhisa, Mitinori Saitou, Yoshiaki Toyama, Toshio Suda, Takeshi Miyamoto: The Blimp1-Bcl6 axis is critical to regulate osteoclast differentitation and bone homeostasis.
 J Experimental Medicine   207(4):751-762,2010.
 
’†‘º@’šŽŸ _“Þ쌧—§•ÛŒ’•ŸŽƒ‘åŠw•ÛŒ’•ŸŽƒŠw•”’·E‹³Žö
—Õ°‰h—{Šw
•aŒ^•Ê‚É‚Ý‚½“œ”A•aŠ³ŽÒ‚Ì”­ÇŽž‚Ì”N—î‚Æ‘ÌŠiA’†‘º’šŽŸA×’JŒ›­A“ú–{ŒöO‰q¶Šw‰ïA1983:30(9):237-246
”ì–ž‚ÌŽ¡—Ã\HŽ–—Ö@A’†‘º’šŽŸA“ú–{“à‰ÈŠwŽGŽA1995:84(8):1273-1278
Characteristics of Japanese Rice Diets, DIABETES, P669-672,
 Teiji Nakamura, Elsevior Science,(1995)
 
[’J@‘ì “ñ–ØE[’J@Ž¨•@ˆôA‰Èˆã‰@@‰@’·
‚ß‚Ü‚¢E•½t_ŒoŠw@ƒNƒŠƒjƒJƒ‹ƒpƒX@EBM
Fukaya T and Nomura Y:  Dimension of and vibrations in the round window menbrane in cats. Ann Otol Rhinol Laryngol 98,438-442,1989
Fukaya T,Nomura Y and Fukushima T: Transient retrocochlear low-frequency sensorineural hearing loss: a new clinical entity.   Laryngoscope 101,643-647,1991
[’J@‘ìFŽ¨•@ˆôA‰ÈR‹ÛÜ‚ÌŽg—p‚¨‚æ‚ÑŠO‰È—Ö@‚ð‚ß‚®‚éƒGƒrƒfƒ“ƒX
EBMƒWƒƒ[ƒiƒ‹ 1,768-771,2000
 
•Ÿ“à@–õ’j Œcœä‹`m‘åŠwˆãŠw•”@‹qˆõ‹³Žö
_Œo“à‰ÈŠw
”]zŠÂ‚ÌŽ©“®’²ß”\‚ÉŠÖ‚·‚錤‹†\False neurotransmitter ‚̉e‹¿‚ɂ‚¢‚Ä[@•Ÿ“à–õ’j(ŠwˆÊ\¿˜_•¶)@1976 ŒcœäˆãŠw@53:239-251
u”]‘²’†Ž¡—ÃKƒCƒhƒ‰ƒCƒ“‚Q‚O‚O‚SvŽÂŒ´KlA‹g–{‚ŽuA•Ÿ“à–õ’j‘¼‹¤’˜A‹¦˜aŠé‰æ(2004)
A randomized, double-blind study comparing the safety and efficacy of clopidogrel versus ticlopidine in Japanese patients with noncardioembolic cerebral infarction.
Fukuuchi Y, Tohgi H, Okudera T, Ikeda Y, Miyanaga Y, Uchiyama S, Hirano M, Shinohara Y, Matsumoto M, Yamaguchi T ACerebrovasc Dis. 2008;25(1-2):40-9.
 
…àV@‰p—m “Œ‹žˆã‰ÈŽ•‰È‘åŠw‘åŠw‰@”]_Œo•a‘ÔŠwE‹³Žö
_Œo“à‰È
Xu H, Miki K, Ishibashi S, Inoue J, Sun LY, Endo S, Sekiya I,  Muneta T, Inazawa J, Dezawa M, Mizusawa H. Transplantation of neuronal cells induced from human mesenchymal stem cells improves neurological functions after stroke without cell fusion. J Neurosci Res, in press
Miki K, Ishibashi S, Sun L, Xu H, Ohashi W, Kuroiwa T, Mizusawa H. Intensity of chronic cerebral hypoperfusion determines white/gray matter injury and cognitive/motor dysfunction in mice. J Neurosci Res 2009;87:1270-81
Ishiguro T, Ishikawa K, Takahashi M, Obayashi M, Amino T, Sato N, Sakamoto M, Fujigasaki H, Tsuruta F, Dolmetsch R, Arai T, Sasaki H, Nagashima K, Kato T, Yamada M, Takahashi H, Hashizume Y, Mizusawa H. The carboxy-terminal fragment of α1A-calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cells. Acta Neuropathol 2010; 119: 447-46
 
‹{•@Œõ‹g iàjŽ•‰Èˆã—ÃŒ¤CU‹»à’cê–±—Ž–
ŽÐ‰ïŽ•‰ÈŠwAŒöO‰q¶ŠwAŒûo‰q¶Šw
Professional Oral Health Care Reduces the Number of Oropharyngeal Bacteria.A.Ishikawa,T.Yoneyama,K.Hirota,Y.miyake,and K.miyatake.Journal of Dental Research,87(6)594`598,2008D
u‰q¶ŠwEŒöO‰q¶Šwv‹{•Œõ‹gA“nç²’B•vAŽ´Î@‘AìŒû—zŽq•Ò’˜A
ˆãŽ•–òo”ÅiŠ”jAi2008j
Handbook of Dental Care:Diagnostic,Preventive and Restrative Services. A.Ishikawa,Y.miyake,T.Yoneyama & K.miyatake.et.al.Nova Science Publishers,Inc.(2009)
 
ŽºŒ´@–L–¾ –¼ŒÃ‰®‘åŠw@zŠÂŠí“à‰È@‹³Žö
zŠÂŠí“à‰ÈŠwAŒŒŠÇ¶•¨ŠwAĶˆã—Ã
Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275: 964-967.
Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T. for the Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002; 360: 427-435.
shii H, Amano T, Matsubara T, Murohara T. Pharmacological intervention for prevention of left ventricular remodeling and improving prognosis in myocardial infarction. Circulation. 2008; 118: 2710-2718.
–îè@‹`—Y “Æ—§s­–@l‘—§•a‰@‹@\
zŠÂŠíŠw
A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332(6163):411-415, 1988. M. Yanagisawa, et. al.
Tyronsine phosphorylation of the EGE receptor by the kinase JAK2 is induced by growth hormone. Nature 390(6655):91-96, 1997. T. Yamauchi, et al.
u“à‰ÈŠw@‘æ‹ã”Åv–îè‹`—Y‘•ÒWA’©‘q‘“XA(2007)D
 
ŽR“c@–¾ ˆÇ—Ñ‘åŠwˆãŠw•”‘æˆê“à‰ÈE‹³Žö
t‘Ÿ•aŠwAƒŠƒEƒ}ƒ`äPŒ´•aŠw
Classification of clinical subtypes, patient survival, kidney prognosis, and relapse in patients with MPO-ANCA-associated vasculitis: a single-center experience. Nakabayashi K, Arimura Y, Yoshihara K, Fukuoka T, Karube M, Yamato T, Koji H, Ikegaya N, Ohtuka T, Kawashima S, Sudo M, Yamada A: Mod Rheumatol 19: 420-426, 2009.
Tubulointerstitial nephritis without glomerular lesions in three patients with myeloperoxidase-ANCA-associated vasculitis. Nakabayashi K, Sumiishi A, Sano K, Fujioka Y, Yamada A, Karube M, Koji H, Arimura Y, Nagasawa T: Clin Exp Nephrol, 13: 605-613, 2009.
’†“Å«táŠQ.@u“à‰ÈŠw@‘æ11Í@tE”A˜HŒn‚ÌŽ¾Š³vŽR“c–¾@™–{P–¾A–îè‹`—Y‘•ÒW@’©‘q‘“X@2007

(Š¯EŽw’èj
ˆã­‹ÇŽw“±‰Û’·
Œ’N‹ÇŽ¾•a‘Îô‰Û’·
Œ’N‹Ç¶Šˆ‰q¶‰Û’·
Œ’N‹Ç‘–±‰Û¶ŠˆKŠµ•a‘ÎôŽº’·

ƒz[ƒ€ > ­ô‚ɂ‚¢‚Ä > •ª–ì•Ê‚Ì­ôˆê—— > ‘¼•ª–ì‚ÌŽæ‚è‘g‚Ý > Œ¤‹†Ž–‹Æ > ˆÈ‘Oi•½¬9`22”N“xjŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à‚ÌŠT—v > •½¬22”N“xŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à‚ÌŠT—v > ’†ŠÔEŽ–Œã•]‰¿ˆÏˆõ‰ï–¼•ë > zŠÂŠíŽ¾Š³E“œ”A•a“™¶ŠˆKŠµ•a‘Îô‘‡Œ¤‹†Ž–‹Æ@’†ŠÔEŽ–Œã•]‰¿ˆÏˆõ–¼•ë

ƒy[ƒW‚Ì擪‚Ö–ß‚é